Akebia Therap

AKBA
0.40135.69% ( -0.0242 )
Closed: Nov 6, 16:00:00 (EDT)

Current ValuationThe current P/E ratio is -2.65, within the reasonable range, cheaper than 33.38% of the time in the past 5 years, and the industry ranks 320/606, the industry Median -1.77.

-2.65xP/E
Stock price$0.43Earnings per share$-0.16

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
013263952

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
GILDUSGilead Sciences
-53.82x161.61%$207.84B
MRNAUSModerna
-30.59x16.99%$96.40B
CSLLYUSCSL Limited
-25.97x--$66.97B
NTRAUSNatera
-272.60x5.57%$52.43B
RVMDUSRevolution Medicines
-20.36x61.94%$38.08B
ROIVUSRoivant Sciences
-99.35x146.69%$26.45B
INSMUSInsmed
-39.40x75.15%$23.86B
BNTXUSBioNTech SE
-12.74x21.80%$21.57B
BBIOUSBridgebio Pharma
-24.43x31.08%$14.47B
SMMTUSSummit Therapeutics
-13.59x20.06%$11.32B
BMRNUSBioMarin Pharma
-568.62x60.62%$10.87B
KYMRUSKymera Therapeutics
-30.49x8.45%$10.65B
PCVXUSVaxcyte
-8.49x47.91%$9.75B
MDGLUSMadrigal Pharma
-59.46x90.48%$9.24B
SYREUSSpyre Therapeutics
-38.02x44.63%$8.52B
IBRXUSImmunityBio
-8.55x151.32%$8.49B
ARWRUSArrowHead Pharma
-25.37x35,923.70%$8.12B
TWSTUSTwist Bioscience
-58.08x28.63%$7.94B
CYTKUSCytokinetics
-9.93x7.04%$7.72B
ALKSUSAlkermes
-21,288.25x133.86%$7.47B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.